100 related articles for article (PubMed ID: 2328195)
1. Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Br J Clin Pharmacol; 1990 Apr; 29(4):473-7. PubMed ID: 2328195
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects.
Williams MP; Blanshard C; Millson C; Sercombe J; Pounder RE
Aliment Pharmacol Ther; 2000 Jun; 14(6):691-9. PubMed ID: 10848651
[TBL] [Abstract][Full Text] [Related]
3. The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Gavey CJ; Smith JT; Nwokolo CU; Pounder RE
Aliment Pharmacol Ther; 1989 Dec; 3(6):557-64. PubMed ID: 2577500
[TBL] [Abstract][Full Text] [Related]
4. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.
Lanzon-Miller S; Pounder RE; Hamilton MR; Ball S; Chronos NA; Raymond F; Olausson M; Cederberg C
Aliment Pharmacol Ther; 1987 Jun; 1(3):239-51. PubMed ID: 2979226
[TBL] [Abstract][Full Text] [Related]
5. Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration.
Fraser AG; Sawyerr AM; Hudson M; Smith M; Pounder RE
Dig Dis Sci; 1994 Jan; 39(1):91-6. PubMed ID: 8281874
[TBL] [Abstract][Full Text] [Related]
6. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
7. The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects.
Lanzon-Miller S; Pounder RE; Ball SG; Dalgleish DJ; Coward J; Jackson AO
Scand J Gastroenterol; 1988 Mar; 23(2):244-50. PubMed ID: 3283919
[TBL] [Abstract][Full Text] [Related]
8. 24-hour intragastric acidity and plasma gastrin after omeprazole treatment and after proximal gastric vagotomy in duodenal ulcer patients.
Lind T; Cederberg C; Olausson M; Olbe L
Gastroenterology; 1990 Dec; 99(6):1593-8. PubMed ID: 2227275
[TBL] [Abstract][Full Text] [Related]
9. Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia.
Lanzon-Miller S; Pounder RE; Hamilton MR; Chronos NA; Ball S; Mercieca JE; Olausson M; Cederberg C
Aliment Pharmacol Ther; 1987 Jun; 1(3):225-37. PubMed ID: 2979225
[TBL] [Abstract][Full Text] [Related]
10. The effect of indomethacin-induced gastric mucosal injury on 24-h intragastric acidity and plasma gastrin concentration in healthy volunteers.
Rademaker JW; Rainsford KD; Stetsko PI; Johnson DM; Chiba N; McDonald TM; Hunt RH
Aliment Pharmacol Ther; 1995 Dec; 9(6):625-31. PubMed ID: 8824649
[TBL] [Abstract][Full Text] [Related]
11. Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects.
Prewett EJ; Smith JT; Nwokolo CU; Sawyerr AM; Pounder RE
Clin Sci (Lond); 1991 Jun; 80(6):619-24. PubMed ID: 1647926
[TBL] [Abstract][Full Text] [Related]
12. The effect of fasting on 24-hour intragastric acidity and plasma gastrin concentration.
Lanzon-Miller S; Pounder RE
Am J Gastroenterol; 1991 Feb; 86(2):165-7. PubMed ID: 1992628
[TBL] [Abstract][Full Text] [Related]
13. The effects of 15 days of dosing with placebo, sufotidine 600 mg nocte or sufotidine 600 mg twice daily upon 24-hour intragastric acidity and 24-hour plasma gastrin.
Rogers MJ; Holmfield JH; Primrose JN; Johnston D
Aliment Pharmacol Ther; 1990; 4 Suppl 1():65-74. PubMed ID: 1983347
[TBL] [Abstract][Full Text] [Related]
14. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
15. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
16. Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects.
Smith JT; Pounder RE
Gut; 1990 Mar; 31(3):291-3. PubMed ID: 1969833
[TBL] [Abstract][Full Text] [Related]
17. Interrelationship between gastric acidity and gastrin concentration in patients with duodenal or gastric ulcer and in healthy subjects.
Mahachai V; Walker K; Pinchbeck B; Thomson AB
Clin Ther; 1985; 7(4):424-41. PubMed ID: 4016826
[TBL] [Abstract][Full Text] [Related]
18. Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study.
Nwokolo CU; Prewett EJ; Sawyerr AM; Hudson M; Lim S; Pounder RE
Gastroenterology; 1991 Oct; 101(4):948-53. PubMed ID: 1889719
[TBL] [Abstract][Full Text] [Related]
19. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men.
Katelaris PH; Seow F; Lin BP; Napoli J; Ngu MC; Jones DB
Gut; 1993 Aug; 34(8):1032-7. PubMed ID: 8174948
[TBL] [Abstract][Full Text] [Related]
20. Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man.
Nwokolo CU; Sawyerr A; Smith JT; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():75-83. PubMed ID: 1983349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
